Comparison of the Effectiveness of USG-Guided Interscalene Block Versus Combined Interscalen-Suprascapular Block for Arthroscopic Shoulder Surgery

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorAsuman Ocaklar

About this trial

This study aims to compare two commonly used regional anesthesia techniques for shoulder arthroscopy: the ultrasound-guided interscalene block and the combined interscalene-suprascapular nerve block. Both techniques are routinely performed to reduce pain during and after shoulder surgery. The purpose of this study is to determine which method provides better postoperative pain control, reduces the need for pain medication, and causes fewer side effects such as diaphragmatic dysfunction. Participants will receive one of the two nerve block techniques before surgery, and their pain scores, opioid consumption, and respiratory effects will be monitored during the first 24 hours after the operation.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Ultrasound-Guided Interscalene Block

    Procedure/Surgery

    An ultrasound-guided interscalene brachial plexus block performed at the C5-C6 level using a high-frequency linear ultrasound probe. Local anesthetic is injected around the brachial plexus under real-time ultrasound visualization. This technique represents the standard regional anesthesia method for arthroscopic shoulder surgery.

  • Combined Ultrasound-Guided Interscalene and Suprascapular Nerve Blocks

    Procedure/Surgery

    A combined regional anesthesia technique consisting of an ultrasound-guided interscalene block performed at the C5-C6 level, followed by an ultrasound-guided suprascapular nerve block administered at the suprascapular notch. Local anesthetic is injected around both the brachial plexus and the suprascapular nerve under ultrasound guidance. This technique aims to improve postoperative analgesia while potentially reducing phrenic nerve involvement.

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: Interscalene Block (ISB)Active comparator 1 intervention
Group B: ISB+ Suprascapular Block ( ISB+ SSNB)Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Postoperative Pain Score (VAS 0-24 Hours)

Postoperative pain intensity will be assessed using a standard 0-10 Visual Analog Scale (VAS), where 0 indicates no pain and 10 indicates the worst imaginable pain. Pain scores will be recorded at predefined postoperative time points (e.g., 1, 2, 6, 12, and 24 hours). The primary outcome will be the comparison of cumulative VAS scores between the interscalene block group and the combined interscalene-suprascapular block group during the first 24 postoperative hours.

Time frame
0-24 hours after surgery

Secondary outcomes

1

Total Postoperative Opioid Consumption (0-24 Hours)

Total postoperative opioid consumption will be recorded during the first 24 hours after surgery. All opioid medications will be converted to intravenous morphine milligram equivalents (MME) for standardized comparison between groups. The cumulative opioid requirement of the interscalene block group will be compared with that of the combined interscalene-suprascapular block group.

Time frame
0-24 hours after surgery

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Asuman Ocaklar

Lead sponsor

Gaziantep City Hospital

Sponsor institution

This trial is not recruiting at the moment. You can still explore other options: